The present invention relates to novel antidiabetic, hypolipidemic,
antiobesity and hypocholesterolemic compounds of formula (I) their
derivatives, their analogs, their tautomeric forms, their stereoisomers,
their polymorphs, their pharmaceutically acceptable salts, their
pharmaceutically acceptable solvates and pharmaceutically acceptable
compositions containing them, to a process for preparing such compounds.
More particularly, the present invention relates to novel alkyl
carboxylic acids of the general, their derivatives, their analogs, their
tautomeric forms, their stereoisomers, their polymorphs, their
pharmaceutically acceptable salts, their pharmaceutically acceptable
solvates and pharmaceutically acceptable compositions containing them, to
a process for preparing such compounds. The present invention also
relates to processes for the preparation of the compounds of formula (I),
novel intermediates, processes for their preparation, their use in the
preparation of the above said compounds and their use as antidiabetic,
hypolipidemic, antiobesity and hypocholesterolemic compounds. 1
